---
schema_version: "secwatch.filing_event.v1"
accession: "0001844505-24-000076"
form_type: "8-K"
ticker: "QTI"
cik: "0001844505"
company_name: "QT IMAGING HOLDINGS, INC."
filed_at: "2024-11-13T23:59:59+00:00"
generated_at: "2026-05-30T01:04:57.276608+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# QT Imaging Q3 scanner sales $0.9M (65% gross margin); amends convertible note to $8.6M; insider PIPE $2.56M

## Summary
- Generated $0.9M scanner sales revenue with 65% gross margin in Q3 2024.
- Completed engineering and clinical feasibility study with strategic partner.
- Amended $10M convertible note with YA II PN: principal reduced to $8.6M, maturity extended to March 2026.
- Board members and affiliates invested $2.56M PIPE at ~10% premium; surrened $1.56M note and $1M new cash.
- Third-year renewal of NIH/NCI research grant signed during quarter.

## SEC filing metadata
- accession: 0001844505-24-000076
- form_type: 8-K
- ticker: QTI
- cik: 0001844505
- company_name: QT IMAGING HOLDINGS, INC.
- filed_at: 2024-11-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1844505/000184450524000076/0001844505-24-000076-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1844505/000184450524000076/qti-20241113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001844505-24-000076
- JSON: https://secwatch.observer/filing/0001844505-24-000076.json
- Plain text: https://secwatch.observer/filing/0001844505-24-000076.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.